Dr.Shweta Viswanath

Prof.Subhash Dadeya, Dr. RITU ARORA, Dr.Jigyasa Sahu

Abstract

The study conducted was a Prospective Interventional Study.

Patients with a baseline myopia of ≥-2.0D were randomised into two groups, Group A received 0.01% atropine eye drops and Group B received artificial tear drops every day at night. Spherical equivalent(SE) and axial length(AL) were measured to assess progression. Minimum follow up was one year. A total of 60 eyes were included.

Mean age was: Group A(n=30): 11.33 ± 3.31 years and Group B(n=30): 10.8 ± 3.41 years (P=0.602). Mean pre interventional SE was Group A: -3.65 ± 1.08D; Group B: -3.8 ± 1.15D (P =0.603). Mean pre interventional AL was Group A: 24.05 ± 1.27mm ;Group B: 24.62 ± 0.9mm (P =0.068) .The progression of SE in two groups was : Group A: -0.53 ± 0.16D; Group B: -1.01 ± 0.50D(P=0.01); and the progression of AL in two groups was : Group A: 0.16 ± 0.03mm ; Group B: 0.31 ±0.01mm (P=0.008).

0.01% atropine eye drops are a safe and effective treatment modality in reducing myopia progression in Indian children.